Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The L1 protein is the major capsid protein of human papillomavirus type 11 (HPV-11), a small, non-enveloped, double-stranded DNA virus. It is essential for forming the viral capsid and plays a central role in the assembly of virus-like particles (VLPs) used in HPV vaccines. The L1 protein self-assembles into pentameric structures (capsomeres) which then form an icosahedral capsid. The C-terminal region contains a DNA-binding domain. VLPs composed of recombinant HPV type 11 L1 induce strong type-specific immune responses. The use of HPV vaccines has proven to be highly effective in preventing HPV infections and associated diseases.
The L1 protein is the primary antigen used in HPV vaccines. VLPs formed by L1 stimulate a strong neutralizing antibody response, preventing viral infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus Type 11 L1 Capsid Protein (HPV-11 L1).